Progressive multifocal leukoencephalopathy in patients with HIV infection

Journal of NeuroVirology

Volumn 4, Issue 1, 1998, Pages 59-68

  Berger, Joseph R ^a,f   Pall, Lorraine ^d,e   Lanska, Douglas ^a,b,c   Whiteman, Michelle ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Neurology Service   (United States)

^d LEXINGTON VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

AIDS; Human immunodeficiency virus; JC virus; Progressive mutlifocal leukocencephalopathy; Type 1

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GAIT DISORDER; HEADACHE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR FOSSA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIODIAGNOSIS; RISK FACTOR; SCHOOL CHILD; SPEECH DISORDER; SURVIVAL TIME; VISUAL IMPAIRMENT;

EID: 0031939019     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809113482     Document Type: Article

References (64)

1. Åstrom KE, Mancall EL, Richardson Jr EP (1958). Progressive multifocal leukoencephalopathy. Brain 81: 92-127.
2. Bacellar H, Munoz A, Miller EN, et al. (1994). Temporal trends in the incidence of HIV-1-related neurologic disease: Multicenter AIDS Cohort Study, 1985-1992. Neurology 44: 1892-1900.
3. Bauer WR, Turel Jr AP, Johnson KP (1973). Progressive multifocal leukoencephalopathy and cytarabine: remission with treatment. JAMA 226: 174-176.
4. Berger JR, Kaszovitz B, Post JD, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature and report of 16 cases. Ann Intern Med 107: 78-87.
5. Berger JR, Mucke L (1988). Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 38: 1060-1064.
6. Berger JR, Scott G, Albrecht J, Belman A, Tornatore C, Major EO (1992). Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS 6: 837-841.
7. Berger JR, Stein N, Pall L (1996). Headache and HIV infection: a case control study. European Neurol 36: 229-233.
8. Brooks BR, Walker DL (1984). Progressive multifocal leukoencephalopathy. Neurol Clin 2: 299-313.
9. Buckman R, Wiltshaw E (1976). Progressive multifocal leukoencephalopathy successfully treated with cytosine arabinoside. Br J Haematol 34: 153-158.
10. Burger H, Belman AL, Crimson R et al. (1990). Long HIV-1 incubation periods and dynamics of transmission within a family. Lancet 336: 1234-1236.
11. Cavanaugh JB, Greenbaum D, Marshall A, Rubinstein L (1959). Cerebral demyelination associated with disorders of reticuloendothelial system. Lancet ii: 524-529.
12. Colosimo C, Lebon P, Martelli M, Tumminelli F, Mandelli F (1992). Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 92: 24-29.
13. Conomy JP, Beard NS, Matsumoto H, Roessmann U (1974). Cytarabine treatment of progressive multifocal leukoencephalopathy. JAMA 229: 1313-1316.
14. Conway B, Halliday WC, Brunham RE (1990). Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3′-azido-3′-deoxythyrnidine. Rev Infect Dis 12: 479-482.
15. Elovaara I, Iivanainen M, Valle S-L, Suni J, Tervo T, Lähdevirta J (1987). CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J Neurol Sci 78: 331-342.
16. Fiala M, Cone LA, Cohen N, et al. (1988). Responses of neurologic complications of AIDS to 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl) luanine. I. Clinical features. Rev Infect Dis 10: 250-256.
17. Fong IW, Toma E (1995). The natural history of progressive multifocal leukoencephalopathy in patients with AIDS Canadian PML Study Group. Clin Infect Dis 20: 1305-1310.
18. Fong IW, Britton CV, Luinstra KK, Toma E, Mahony JB (1995). Diagonstic value of detecting virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33: 484-486.
19. Gillespie SM, Chang Y, Lemp G, et al. (1991). Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Franciso, 1981-1989. Ann Neural 30: 597-604.
20. Hall CD, Dafni U, Simpson D, et al. (1998). Failure of cytosine arabinoside therapy for human immunodeficiency virus-1 associated progressive multifocal leukoencephalopathy. N Eng J Med (in press).
21. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM. (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 54: 19-28.
22. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991). Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 41: 1733-1736.
23. Houff SA, Major EO, Katz D, et al. (1988). Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318: 301-305.
24. Katz RL, Alappattu C, Glass JP, Bruner JM (1989). Cerebrospinal fluid manifestsations of the neurologic complications of human immunodeficiency virus infection. Acta Cytologica 33: 233-244.
25. Katz DA, Berger JR, Hamilton B, Major EO, Post MJD (1994). Progressive multifocal leukoencephalopathy complicating Wiskott-Aldrich syndrome. Arch Neurol 51: 422-426.
26. Krupp LB, Lipton RB, Swerdlow ML, Leedes NE, Llena J (1985). Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 17: 344-349.
27. Kuchelmeister K, Gullotta F, Bergmann M, Angeli F, Masini T. (1993). Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Path Res Pract 189: 163-173.
28. Kure K, Llena JF, Lyman WD, et al. (1991). Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adults, pediatric and fetal brains. Hum Pathol 22: 700-710.
29. Lang W, Miklossy J, Deruaz JP, et al. (1989). Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 77: 379-390.
30. Major EO, Amemiya EE, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JV virus-induced demyelinating disease of the human brain. Clin Microbiol 5: 49-73.
31. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN (1988). Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45: 954-958.
32. Martin-Suarez I, Aguayo Canela M, Merino Munoz D, Pujol de la Llave E (1994). Prolonged surival in patients with progressive multifocal leukoencephalopathy associated with AIDS treated with high doses of zidovudine (letter). Rev Clin Esp 194: 136-138.
33. McGuire D, Barhite S, Hollander H, Miles M (1995). JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37: 395-399.
34. Messite J, Stellman SD (1996). Accuracy of death certificate completion. JAMA 275: 794-796.
35. Miller J, Barrett R, Britton C (1982). Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. New Engl J Med 307: 1436-1438.
36. Moore RD, Chaisson RE (1996). Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 124: 633-642.
37. Moulignier A, Mikol J, Pialoux G, Fenelon G, Gray F, Thiebaut F (1995). AIDS-associated progressive multifocal leukoencephalopathy revealed by new onset seizures. Am J Med 99: 64-68.
38. Ng S, Tse VC, Rubinstein J, Bradford E, Enzmann DR, Conley FK (1995). Progressive multifocal leukoencephalopathy: unusual MR findings. J Comput Asst Tomogr 19: 302-304.
39. O'Riordan T, Daly PA, Hutchinson M, Shattuck AG, Gardner SD (1990). Progressive multifocal leukoencephalopathy - remission with cytarabine. J Infect Dis 20: 51-54.
40. Olesen WI, Longo FM, Mills CM, Normal D (1988). White matter disease in AIDS: findings at MRI imaging. Radiology 169: 445-448.
41. Omerud LD, Rhodes RH, Gross SA, Crane LR, Houchin KW (1996). Opthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy. Ophthalmology 103: 899-906.
42. Padgett BL, Walker D L (1983). Viorlogic and serologic studies of progressive multifocal leukoencephalopathy. In: Sever JL, Madden DL. Polyomaviruses and human neurological diseases. Alan R Liss, Inc, New York, pp. 107-117.
43. Padgett BL, ZuRhein G, Walker D, Echroade R, Dessel B. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet i: 1257-1260.
44. Peters ACB, Versteeg J, Bots GTA, et al. (1980). Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of SV40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 37: 497-501.
45. Portegies P, Algra PR, Hollar CEM, Prins JM, Reiss P, Valk J, Lange JMA (1991). Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 337: 680-681.
46. Post MJD, Tate LG, Quencer RM, et al. (1988) CT, MR and pathology in HIV encephalitis and meningitis. AJNR 9; 469-476.
47. Power C, Kong PA, Crawford TO, et al. (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alteration of the blood-brain-barrier. Ann Neurol 34: 339-350.
48. Rhiza HJ, Bornkamm G, ZurHausen H (1978). Seroepidemiological studies and serologic response to viral infection. Med Microbiol Immunol 165: 73-92.
49. Sarrazin JL, Soulie D, Derosier C, Sescop J, Schill H, Cordoliani YS (1995). MRI apsects of progressive multifocal leukoencephalopathy. J Neuroradiol 22: 172-179.
50. Sasseville VG, Newman WA, Lackner AA, et al. (1992) Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simiam immunodeficiency virus. Am J Pathol 141: 1021-1030.
51. Singer EJ, Stoner GL, Singer P, Tomiyasu U, Licht E, Gahy-Chandon B, Tourtellotte WW (1994). AIDS presented as progressive multifocal leukoencephalopathy with clinical respone to zidovudine. Acta Neurol Scan 90: 443-447.
52. Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH (1993). Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33: 407-411.
53. Stoner GL, Ryschkewitsch CF, Walker DL, Webster HD (1986). JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 23: 2271-2275.
54. Sweeney BJ, Manji H, Miller RF, Harrison MJ, Gray F, Scaravilli F (1994). Cortical and subcortical JC virus infection: two unusual cases of AIDs associated progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 57: 994-997.
55. Tada H, Rappaport J, Lashgari M, et al. (1990). Transactivation of the JC virus late promoter by the tat protein of the type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479-3483.
56. von Einsiedel RW, Fife TD, Aksamit AJ, et al. (1993). Progressive multifocal leukoencephalopathy in AIDS: a clinicopathological study and review of the literature. J Neurol 240: 391-406.
57. Walker DL, Padgett BL (1983). The epidemiology of human polyomavirus. In: Sever JL, Madden D (eds) Polyomaviruses and human neurological disease. Alan R. Liss, Inc., New York, pp. 99-106.
58. Weber T, Turner RW, Frye S, Kretzschmer HA, Luer W, Hunsmann G. (1994). Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8: 49-57.
59. Wheeler L, Truwit CL, Kleinschmidt-DeMasters BK, Byrne WR, Hannon RN (1993). Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 161: 1049-1051.
60. Whiteman M, Post MJD, Berger JR, Limonte L, Täte LG, Bell M (1993). PML in 47 HIV+patients. Radiology 187: 233-240.
61. Wong MC, Suite ND, Labar DR (1990). Seizures in human immunodeficiency virus infection. Arch Neurol 47: 670-642.
62. Wrozlek MA, Brudkowska J, Kozlowski PB, et al. (1995). Opportunistic infections of the central nervous system in children with HIV infection: repot of 9 cases and review of the literature. Clin Neuropathol 14: 187-194.
63. ZuRhein GM (1969). Association of papovirions with a human demyelinating disease (progressive multifocal leukoencephalopathy). Prog Med Virol 11: 185-247.
64. ZuRhein GM (1967). Polyoma-like virions in a human demyelinating disease. Acta Neuropathol 8: 57-68.